Shanghai Medical and Pharmaceutical Journal 2009 Issue 5 shang hai yi yao xing ye xie hui 2009 nian du tu chu san ge fang mian de gong zuo zhong dian

Home | Survey | Payment| Talks & Presentations | Job Opportunities

Journals A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Shanghai Medical and Pharmaceutical Journal
1006-1533
2009 Issue 5

shang hai yi yao xing ye xie hui 2009 nian du tu chu san ge fang mian de gong zuo zhong dian
xie xing

..............page:197-198

shang yao yu " da fei " yi duan gong zuo hui yi
huang yan zheng

..............page:199-200

The usage of estrogen in hormone therapy during peri - menopausal period
Li Ruzhi

..............page:200-201

The pros and cons of hormone substitution therapy
Zhang Wei

..............page:202-203

Questions and answers on rational drug usage in the clinical practice of obstetrics and gynecology
Editorial Department

..............page:204-205

The safety of dydrogesterone used in hormone substitution therapy
Lei Caixia

..............page:205-207

Development and clinical evaluation of noval contraceptive drugs
Ma Peiqi

..............page:208-209

Research and development progression of new anti -type 2 diabetes drags
Ma Peiqi

..............page:210-211

ning ju zhuan jia zhi hui , wei zhong yi yao chuang xin he chan ye hua fa zhan ba mai zuo xiang bao xin wan " guo jia zhong da xin yao chuang zhi " ke ji zhuan xiang zai hu qi dong
chong zhong

..............page:212

kang ai zhu she ye lian he hua liao zhi liao zhong wan qi fei xiao xi bao fei ai de lin chuang guan cha
zhang ming juan ; zuo cai feng ; chai lin qiang

..............page:213-215

yi dao su di kang yu 2 xing tang niao bing huan zhe wei xue guan bing bian de xiang guan xing
xu zuo

..............page:215-216

mi dan bai mei yu fang wai ke shu hou chang zhan lian
liang yan

..............page:237

ru he zheng que xuan ze gan mao yao
cai liang ; shi yan fei

..............page:236-237

kou fu bi yun yao man tan
kang jie ; wei hai bo

..............page:235-236

Review on FDA's oversea implementation for Current Good Manufacturing Practice inspection from statistical data
ye you chun ; jia wei

..............page:233-234

Nasal drug delivery systems and its trend of development
huang sheng yan

..............page:230-232

zhong yao fang kai zhan yao xue fu wu de shi jian yu ti hui
yu dao wen ; wang yue qing

..............page:228-229

Analysis on the reasons for domestic pharmaceutical enterprises for relatively lower reporting proportion of adverse drug reaction
Yao Yubing;Chen Yongfa;Shao Rong

..............page:225-227

fan long duan fa dui yi yao xing ye de ying xiang
yu na ; shao rong

..............page:222-224

mei ying ji bing guan li mo shi ji dui wo guo de qi shi
hua hui ; yu zheng

..............page:219-222

Discussion on patent purse seining strategy of domestic pharmaceutical enterprises
Zhang Yan

..............page:217-219